Preserve
发表于 2025-3-30 11:31:16
Evaluation of Autoparametric Vibration Absorbers on N-Story Building-Like Structures,system, and synthesized on active vibration control schemes. The overall dynamic performance is experimentally validated on a 6-story building-like structures and a cantilever-type autoparametric absorber, resulting in good attenuation properties.
crutch
发表于 2025-3-30 15:06:53
carriers, pharmacogenomics, personalized medicine, bioequivalence studies, biowaivers, biopharmaceuticals, pharmacokinetic drug interactionsor in silico and in vitro assessment of ADME properties.978-3-030-51519-5
谆谆教诲
发表于 2025-3-30 16:49:45
http://reply.papertrans.cn/67/6675/667459/667459_53.png
mastoid-bone
发表于 2025-3-30 23:02:34
http://reply.papertrans.cn/67/6675/667459/667459_54.png
引导
发表于 2025-3-31 01:36:21
H.-G. Kim,R. Wiebe carriers, pharmacogenomics, personalized medicine, bioequivalence studies, biowaivers, biopharmaceuticals, pharmacokinetic drug interactionsor in silico and in vitro assessment of ADME properties.978-3-030-51519-5
Gum-Disease
发表于 2025-3-31 07:02:24
A. J. Elliott,A. Cammarano,S. A. Neild carriers, pharmacogenomics, personalized medicine, bioequivalence studies, biowaivers, biopharmaceuticals, pharmacokinetic drug interactionsor in silico and in vitro assessment of ADME properties.978-3-030-51519-5
AFFIX
发表于 2025-3-31 11:26:11
http://reply.papertrans.cn/67/6675/667459/667459_57.png
ticlopidine
发表于 2025-3-31 16:50:28
http://reply.papertrans.cn/67/6675/667459/667459_58.png
有限
发表于 2025-3-31 21:24:21
Zhan Hu,Xing Wang,Gangtie Zheng carriers, pharmacogenomics, personalized medicine, bioequivalence studies, biowaivers, biopharmaceuticals, pharmacokinetic drug interactionsor in silico and in vitro assessment of ADME properties.978-3-030-51519-5
制定
发表于 2025-4-1 00:22:13
Vaclav Ondra,Ibrahim A. Sever,Christoph W. Schwingshackl carriers, pharmacogenomics, personalized medicine, bioequivalence studies, biowaivers, biopharmaceuticals, pharmacokinetic drug interactionsor in silico and in vitro assessment of ADME properties.978-3-030-51519-5